Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (Nasdaq: PWUP) is a blank check company formed to identify and complete a business combination with one or more businesses in the biopharma and life sciences sector. The company filed a Form 10-Q with the Securities and Exchange Commission on May 16, 2022, reflecting its status as an active SPAC conducting a search for an acquisition target. Aspire Biopharma completed its initial public offering in 2021, listing on the Nasdaq Capital Market under the PWUP ticker. As of the filing date, the company remained in its pre-combination phase, focused on opportunities in the biopharmaceutical industry. Sign up at SpacDesk for full SPAC data, sponsor details, filing histories, and deal timelines on Aspire Biopharma Holdings and thousands of other SPACs.